Active ingredientTranexamic AcidCat. No. P-T176-001CAS 1197-18-8Family · Pharmaceutical analytical standards
Tranexamic Acid
An antifibrinolytic synthetic analogue of lysine, developed in Japan by the husband and wife team Shosuke and Utako Okamoto, who described it in 1962: it reduces bleeding in surgery, trauma and heavy menstrual periods. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?Utako Okamoto was looking for a medicine against bleeding after childbirth: decades later the international WOMAN trial, launched in 2010, proved its benefit in exactly this setting.
Go to the active ingredient →Active ingredientTranexamic AcidCat. No. P-T176-001CAS 1197-18-8
Pharmacopoeial impurityTranexamic acid EP Impurity BCat. No. P-T176-002CAS 1197-17-7
Pharmacopoeial impurityTranexamic acid EP Impurity ECat. No. P-T176-003CAS 82755-59-7
Pharmacopoeial impurityTranexamic acid EP Impurity FCat. No. P-T176-004CAS 1599413-49-6
Pharmacopoeial impurityTranexamic Acid EP Impurity ACat. No. P-T176-005CAS 93940-19-3
Pharmacopoeial impurityTranexamic Acid EP Impurity A HClCat. No. P-T176-006
Pharmacopoeial impurityTranexamic Acid EP Impurity C HydrochlorideCat. No. P-T176-007CAS 1803601-44-6
Pharmacopoeial impurityTranexamic Acid EP Impurity CCat. No. P-T176-008CAS 330838-52-3
Pharmacopoeial impurityTranexamic Acid EP Impurity DCat. No. P-T176-009CAS 56-91-7
Isotopically labelledN-Nitroso Tranexamic Acid EP Impurity A-d4Cat. No. P-T176-012
Isotopically labelledTranexamic Acid EP Impurity A-d4Cat. No. P-T176-014
NitrosamineN-Nitroso Tranexamic Acid EP Impurity ACat. No. P-T176-016
ImpurityTranexamic Acid Impurity 1Cat. No. P-T176-017CAS 2057-25-2
ImpurityTranexamic Acid Impurity 2Cat. No. P-T176-018CAS 17770-36-4
ImpurityTranexamic Acid Impurity 3Cat. No. P-T176-019CAS 2375016-71-8
Impurity4-Methylcyclohexanecarboxylic acidCat. No. P-T176-020CAS 13064-83-0
ImpurityTranexamic Acid Bicyclic ImpurityCat. No. P-T176-022CAS 5592-68-7
ImpurityTranexamic Acid Ethyl Ester HydrochlorideCat. No. P-T176-023CAS 19878-18-3
ImpurityTranexamic Acid Impurity 4Cat. No. P-T176-024
ImpurityTranexamic Acid Impurity 4 HydrochlorideCat. No. P-T176-025
ImpurityTranexamic Acid Impurity 5 DihydrochlorideCat. No. P-T176-026
ImpurityTranexamic Acid Impurity 7 HydrochlorideCat. No. P-T176-028
ImpurityTranexamic Acid Isopropyl Ester HydrochlorideCat. No. P-T176-031CAS 38698-13-4
ImpurityTranexamic Acid Methyl Ester HydrochlorideCat. No. P-T176-032CAS 29275-88-5
Impuritytrans-Tranexamic Acid Impurity 8Cat. No. P-T176-033No product matches your search.
EDQM standards 6
The official European Pharmacopoeia standards for this family.
Reference substanceTranexamic acid CRSEDQM code T1810000Family Tranexamic AcidImpurityTranexamic acid impurity B CRSEDQM code Y0002155Family Tranexamic AcidImpurityTranexamic acid impurity C CRSEDQM code Y0002154Family Tranexamic AcidImpurityTranexamic acid impurity D CRSEDQM code Y0002162Family Tranexamic AcidImpurityTranexamic acid impurity E CRSEDQM code Y0002149Family Tranexamic AcidImpurityTranexamic acid impurity F CRSEDQM code Y0002153Family Tranexamic AcidNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.